Intuitive, a global leader in minimally invasive care and robotic-assisted surgery, has received clearance from the U.S. Food and Drug Administration (FDA) for its Vessel Sealer Curved instrument, designed for use with the company's multiport da Vinci surgical systems.

The Vessel Sealer Curved is a fully wristed, advanced bipolar electrosurgical tool developed to grasp, dissect, seal, and cut tissue. It is the first advanced energy instrument from Intuitive to receive FDA approval for cutting lymphatic vessels.

With a slim, curved jaw, the instrument is engineered to closely follow anatomical contours, offering improved visibility and control in confined areas and around delicate structures. Its mechanical blade is positioned closer to the tip, enhancing its use as both a sealer and dissector.

The FDA has approved the Vessel Sealer Curved for a range of surgical applications, including blunt dissection, tissue grasping, bipolar coagulation, and mechanical cutting of blood vessels—both veins and arteries—up to 7 mm in diameter. It is also approved for transecting lymphatic vessels and tissue bundles that can be enclosed within the instrument's jaws. However, it is not authorised for use in tubal sterilisation or coagulation procedures.

The launch coincides with Intuitive’s 30th anniversary. Since its founding, nearly 17 million procedures have been performed using its da Vinci systems, and around 90,000 surgeons have been trained to use the technology. The company continues to focus on enhancing patient outcomes, supporting surgical teams, expanding access to minimally invasive care, and reducing overall treatment costs.

 

Source: globenewswire.com

Report Abuse